• SENSEX 81,833.78
    -77.23 (--0.09%)
  • BANKNIFTY 61,518.50
    726.10 (+1.19%)
  • NSE
    1,981.80 1,640.25(%)
  • Hitachi Energy
    30,733.25 38,800.00(%)
  • Home First Finan
    1,091.50 893.95(%)
  • TD Power Systems
    661.80 856.00(%)
  • Kalyan Jewellers
    724.15 716.00(%)
  • Cupid
    393.40 389.00(%)
  • Manappuram Fin.
    319.40 245.10(%)
  • Meesho
    257.40 259.00(%)
  • SBI
    1,094.00 1,234.80(%)
  • Afcom Holdings
    1,525.00 1,711.00(%)
  • HDFC Bank
    802.35 668.90(%)
  • Jio Platforms
    1,404.90 1,490.00(%)
  • Sai Life
    1,925.00 1,940.20(%)
  • Vodafone Idea
    12.55 8.14(%)
  • Amber Enterp.
    6,310.00 8,970.00(%)
  • Ola Electric
    33.80 20.83(%)
  • Kennametal India
    4,167.75 5,110.35(%)
  • Reliance Industries
    1,328.10 1,152.30(%)
  • Bajaj Finance
    1,090.00 788.40(%)
  • One 97
    1,926.05 1,923.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Asston Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 94417.0
  • ISIN : INE0SJX01015
160.30 5 (3.25%)
  • As on 13 Nov 2026 (EOD)

  • Today’s Low

    151.00

  • Today’s High

    161.00

  • Open

    154.00

  • Perv Close

    155.25

  • 52W Low

    60.00

  • 52W High

    161.00

Key Indicators

  • P/E(TTM)

    44.78

  • Mar.Cap (₹Cr.)

    175.09

  • Div & Yield %

    0.00

  • Book Value(₹)

    60.96

  • Debt-Equity Ratio

    3.25

  • AGM Date

    12-Nov-2026

  • EPS

    3.58

  • P/E Ratio

    44.78

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    175.09

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    10.92

  • BV (₹)

    61.00

  • Sales( ₹ in Cr.)

    25.47

  • NP (in Cr.)

    3.91

  • NP Var(%)

    3.0

  • Div%

    0.0

  • CPS (₹)

    3.90

  • EPS (₹)

    3.60

  • Traded Value (₹ in Lakhs)

    175.09

  • 52 Week High

    161.00

  • 52 Week Low

    60.00

  • Price BSE

    160.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    175.09

  • P/C Ratio

    41.20

  • P/E Ratio

    44.70

  • Price Vs.BV

    3.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar
INCOME :            
Sales Turnover 25.47 25.04 16.03 6.54 9.60 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 25.47 25.04 16.03 6.54 9.60 -
Other Income 6.12 0.57 0.25 0.65 0.96 -
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 -
Total Income 31.59 25.61 16.28 7.19 10.56 -
EXPENDITURE :            
Raw Materials 17.41 14.14 9.75 2.68 6.70 -
Power and Fuel Cost 0.17 0.14 0.01 0.00 0.00 -
Employee Cost 1.62 1.06 0.19 0.23 0.26 -
Other Manufacturing Expenses 0.55 0.21 0.12 0.67 0.98 -
Selling and Administration Expenses 4.99 3.17 2.13 1.42 2.00 -
Miscellaneous Expenses 1.29 0.87 0.01 0.02 0.01 -
Employee Benefit Expenses 1.62 1.06 0.19 0.23 0.26 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 26.03 19.60 12.20 5.02 9.95 -
Operating Profit 5.55 6.01 4.07 2.17 0.60 -
Interest 0.63 0.95 0.76 0.72 0.43 -
Gross Profit 4.92 5.06 3.31 1.45 0.17 -
Depreciation 0.32 0.04 0.06 0.04 0.01 -
Profit Before Tax 4.60 5.02 3.25 1.41 0.16 -
Current Tax 0.62 1.22 0.81 0.34 0.03 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax 0.11 -0.06 0.01 0.02 0.02 -
Reported Net Profit 3.87 3.85 2.43 1.06 0.11 -
Extraordinary Items -0.05 0.07 0.00 0.00 0.00 -
Adjusted Net Profit 3.92 3.78 2.43 1.06 0.11 -
Adjustment below Net Profit 0.00 -2.53 0.00 0.00 0.00 -
P & L Balance brought forward 4.76 3.44 1.01 0.23 0.12 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 0.00 0.00 0.00 0.00 0.00 -
P & L Balance carried down 8.63 4.76 3.44 1.29 0.23 -
Dividend 0.00 0.00 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr 4.54 6.14 31.01 15.09 1.58 -
Earnings Per Share(Adj)-Unit Curr 4.54 - - - - -
Book Value 45.65 17.60 91.63 28.37 13.28 -
Book Value(Adj)-Unit Curr 45.65 - - - - -

Shareholding Pattern

  • Promoter Group

    39.48%

  • Public Share Holding

    60.52%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,312,480 39.48 4,312,480 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,312,480 39.48 4,312,480 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 897,922 8.22 897,922 15
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 139,678 1.28 139,678 11
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 95,293 0.87 95,293 41
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,853,121 35.28 3,853,121 37
Individuals holding nominal share capital up to Rs. 1 lakh 1,599,961 14.65 1,599,961 566
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,610,311 60.52 6,610,311 672
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,922,791 100.00 10,922,791 675

Company Background

Asston Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs

  • Asston Pharmaceuticals Ltd
  • BSE Code : 94417.0
  • ISIN : INE0SJX01015

  • Incorporation Year

    2019

  • Registered Office

    4th Flr Office No.A-431 Balaji
    Bhavan Plot No.42A Sec-11 CBD, Mumbai,
    Maharashtra-400614

  • Telephone

    +91 22 4973 1411/+91 22 4973 1419

  • FAX

  • Chairman

  • Managing Director

    Ashish Narayan Sakalkar

  • Company Secretary

    Vandana Mishra

  • Auditor

    Doshi Doshi & Co/Panchal S K & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Maashitla Securities Pvt Ltd
    451 Krishna Apra Bus,
    Netaji Subhash Place,Pitampura
    Mumbai - New Delhi-110034

Asston Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Asston Pharmaceu 160.30 31.58 25.47 45.28 16.71
Abbott India 26,603.60 7,217.19 6,929.05 34.20 43.78
Astrazeneca Phar 6,431.20 2,304.07 2,275.58 90.47 27.86
Glaxosmi. Pharma 2,655.30 3,932.76 3,790.20 39.45 58.17
Evonile Pharma 1,583.60 393.10 354.33 -1,389.12 15.94
Cipla 1,410.00 20,102.60 18,979.95 42.97 13.88
Bliss GVS Pharma 641.15 773.53 729.81 41.80 12.51
Amrutanjan Healt 507.50 520.13 502.55 25.61 24.16
Fermenta Biotec. 472.10 474.15 450.25 22.31 18.77
Guj. Themis Bio. 388.05 168.25 165.82 103.76 18.05
Ambalal Sarabhai 36.76 19.52 3.94 62.31 6.77